Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Wolchko Insider Profile
11 Followers
Scott Wolchko, President & CEO, Director at Fate Therapeutics, holds 371.25K shares in Fate Therapeutics (Ticker: FATE). Most recently, Scott Wolchko Sold $14,391 shares of Fate Therapeutics on Jan 10, 2024 for an estimated value of 62.89K.
Scott Wolchko Fate Therapeutics (FATE)President & CEO, Director
Fate Therapeutics (FATE)
President & CEO, Director
Ranked #89,505 out of 98,624 Corporate Insiders
Profitable Transactions
7 out of 11 Profitable Transactions
Average Return
-25.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Scott Wolchko holds in companies
Most Profitable Insider Trade
The most profitable trade made by Scott Wolchko
Scott Wolchko's Trading History
List of latest transactions for each holding click on a transaction to see Scott Wolchko's performance on stock
You May Also Like
Scott Wolchko insider profile FAQ
What is the percentage of profitable transactions made by Scott Wolchko?
The percentage of profitable transactions made by Scott Wolchko is 64%.
What is the average return per transaction made by Scott Wolchko?
The average return per transaction made by Scott Wolchko is -25.90%.
What stocks does Scott Wolchko hold?
Scott Wolchko holds: FATE stocks.
What was Scott Wolchko’s latest transaction?
Scott Wolchko latest transaction was an Informative Sell of $62.89K.
What was Scott Wolchko's most profitable transaction?
Scott Wolchko’s most profitable transaction was an Informative Sell of FATE stock on January 13, 2022. The return on the trade was 87.20%.
What is Scott Wolchko's role in Fate Therapeutics?
Scott Wolchko's role in Fate Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.